[Possibilities of the overlapping of fibrinolytic and elastolytic activity in experimental cholesterine atherosclerosis].
D000818:Animals; D001011:Aorta / Q000473:pathology; D001161:Arteriosclerosis / Q000139:chemically induced / Q000473:pathology*; D002784:Cholesterol / Q000032:analysis*; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008099:Liver / Q000473:pathology; D010179:Pancreas / Q000473:pathology; D010196:Pancreatic Elastase / Q000032:analysis*
D005343:Fibrinolytic Agents; D002784:Cholesterol; D010196:Pancreatic Elastase
Möglichkeit der Uberlagerung fibrinolytischer und elastolytischer Aktivität bei experimenteller Cholesterin-Athersklerose.